Related Experiment Video
Updated: Jun 3, 2026
06:23
Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss
Published on: April 24, 2020
CO2 laser-assisted sclerectomy surgery part I: concept and experimental models
Yokrat Ton1, Noa Geffen, Dvora Kidron
1Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.
Journal of Glaucoma
|March 23, 2011
Summary
This study shows that CO2 laser-assisted sclerectomy surgery is safe and effective for fluid percolation. The OT-134 system demonstrated good performance in experimental models, reducing intraocular pressure.
Area of Science:
- Ophthalmology
- Surgical Technology
- Laser Medicine
Background:
- Glaucoma treatment often involves procedures to reduce intraocular pressure.
- Laser-assisted sclerectomy offers a minimally invasive approach to enhance aqueous humor outflow.
Purpose of the Study:
- To assess the safety and efficacy of a novel second-generation CO2 laser system for assisted sclerectomy.
- To evaluate the performance of the OT-134 device in experimental ocular models.
Main Methods:
- Laser-assisted deep sclerectomy was performed using the OT-134 CO2 laser system in porcine, human cadaver, and rabbit eyes.
- Scleral flaps were created, and deep scleral ablation was achieved over the Schlemm canal.
- Aqueous percolation, perforation rates, intraocular pressure, and histopathological changes were analyzed.
Main Results:
- Successful deep scleral ablation and aqueous percolation were achieved across all experimental models.
- A significant decrease in intraocular pressure was observed in rabbits post-surgery.
- Histopathology revealed deep scleral craters with mild, resolving thermal damage.
Conclusions:
- CO2 laser-assisted sclerectomy with the OT-134 system is a safe and effective method for achieving fluid percolation.
- The experimental results support the potential of this technology for glaucoma management.
